>_ QFI Terminal
TerminalStocks › WAT

Waters Corporation (WAT) Stock

Healthcare · Medical - Diagnostics & Research · US
$421.63 -1.88%
Last updated Sep 20, 2026 13:46 UTC

WAT Key Statistics

Market Cap$31.53B
P/E (TTM)105.14
P/S (TTM)6.79
P/B (TTM)2.72
Revenue (TTM)$4.64B
EPS (TTM)$4.01
Dividend Yield
ROE (TTM)1.88%
Net Margin3.58%
Gross Margin50.78%
52W High$431.78
52W Low$282.77
Analyst ViewBuy
Price Target$438.36
Employees7,900
Volume1,034,974

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

CEO: Udit Batra. Company website

WAT — Frequently Asked Questions

What is the WAT stock price today?

Waters Corporation (WAT) trades at $421.63, down 1.88% on the day, as of Sep 20, 2026 13:46 UTC.

What is Waters Corporation's market cap?

Waters Corporation has a market capitalisation of $31.53B, calculated from the live WAT share price and shares outstanding.

What is the P/E ratio of WAT?

WAT trades at a trailing P/E of 105.14, from earnings per share of $4.01 over the last twelve months.

How much revenue does Waters Corporation make?

Waters Corporation generated revenue of $4.64B over the trailing twelve months, which puts the stock at 6.79 times sales.

What is the 52-week range for WAT?

WAT has traded between $282.77 and $431.78 over the past 52 weeks, and the last price is 2.4% below that high.

Is Waters Corporation profitable?

Yes. Waters Corporation keeps 3.58% of revenue as net income over the trailing twelve months.

What is the analyst price target for WAT?

Wall Street analysts rate WAT Buy, with an average price target of $438.36, 4.0% above the current price.

What sector is Waters Corporation in?

Waters Corporation is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.

Who is the CEO of Waters Corporation?

Udit Batra is the chief executive of Waters Corporation, which employs 7,900 people.

Where can I track WAT in real time?

QFI Terminal shows WAT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See WAT live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open WAT in Terminal See plans

Medical - Diagnostics & Research stocks

TMO Thermo Fisher Scientific Inc. DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. IDXX IDEXX Laboratories, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.